hydofon 50 mg/ ml
2care4 generics aps - hydromorfonhydroklorid - injeksjons-/infusjonsvæske, oppløsning - 50 mg/ ml
losartan medical valley 100 mg
medical valley invest ab - losartankalium - tablett, filmdrasjert - 100 mg
losartan medical valley 12.5 mg
medical valley invest ab - losartankalium - tablett, filmdrasjert - 12.5 mg
losartan medical valley 50 mg
medical valley invest ab - losartankalium - tablett, filmdrasjert - 50 mg
hydromorfonhydroklorid kalceks 10 mg/ ml
as kalceks - hydromorfonhydroklorid - injeksjons-/infusjonsvæske, oppløsning - 10 mg/ ml
hydromorfonhydroklorid kalceks 2 mg/ ml
as kalceks - hydromorfonhydroklorid - injeksjons-/infusjonsvæske, oppløsning - 2 mg/ ml
hydromorfonhydroklorid kalceks 20 mg/ ml
as kalceks - hydromorfonhydroklorid - injeksjons-/infusjonsvæske, oppløsning - 20 mg/ ml
hydromorfonhydroklorid kalceks 50 mg/ ml
as kalceks - hydromorfonhydroklorid - injeksjons-/infusjonsvæske, oppløsning - 50 mg/ ml
reblozyl
bristol myers squibb pharma eeig - luspatercept - anemia; myelodysplastic syndromes; beta-thalassemia - andre antianemic preparations - reblozyl is indicated for the treatment of adult patients with transfusion-dependent anaemia due to very low, low and intermediate-risk myelodysplastic syndromes (mds) with ring sideroblasts, who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy (see section 5. reblozyl is indicated in adults for the treatment of anaemia associated with transfusion dependent and non transfusion dependent beta thalassaemia (see section 5.
rosuvastatin glenmark 40 mg
glenmark arzneimittel gmbh - rosuvastatinkalsium - tablett, filmdrasjert - 40 mg